ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

Affiliations

• ¹ European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
• ² European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland.
• ³ Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.
• ⁴ Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
• ⁵ Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.
• ⁶ Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France.
• ⁷ Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
• ⁸ Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
• ⁹ Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy.
• ¹⁰ Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA.
• ¹¹ Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.
• ¹² University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia.
• ¹³ NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
• ¹⁴ Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
• ¹⁵ Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
• ¹⁶ Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
• ¹⁷ BC Cancer Agency, Vancouver, Canada.
• ¹⁸ Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA.
• ¹⁹ APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France.
• ²⁰ Program of Breast Health, European Institute of Oncology, Milan, Italy.
• ²¹ Brustzentrum der Universität München, Munich, Denmark.
• ²² Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia.
• ²³ Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.
• ²⁴ Sheba Medical Center, Tel Hashomer, Israel.
• ²⁵ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
• ²⁶ Europa Donna Cyprus, Nicosa, Cyprus.
• ²⁷ AdvancedBC.org, New York.
• ²⁸ University of Michigan Medical School and School of Public Health, Ann Arbor, USA.
• ²⁹ Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden.
• ³⁰ Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
• ³¹ Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.
• ³² Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
• ³³ Department of Medicine, Institut Jules Bordet, Brussels, Belgium.
• ³⁴ Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.
• ³⁵ Indiana University Medical CTR, Indianapolis, USA.
• ³⁶ Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.
• ³⁷ Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
• ³⁸ Sandton Oncology Centre, Johannesburg, South Africa.
• ³⁹ Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland.
• ⁴⁰ Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK.
• ⁴¹ Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.